China scores first international regulatory approval with encephalitis vax; Amarin's Vascepa to meet FDA advisory committee;

@FiercePharma: Tops this AM on our website: Novartis eyes sell-offs, with decision on individual units expected soon. More | Follow @FiercePharma

@EricPFierce: Ranbaxy shopping for FDA approved plant. Article | Get all FiercePharmaManufacturing headlines via email | Follow @EricPFierce

@CarlyHFierce: GSK has always said it would be difficult to copy its respiratory drug Advair--and Teva agrees. Article | Follow @CarlyHFierce

> Chengdu Institute of Biological Products became the first Chinese company to have one of its drugs or vaccines approved internationally; its vaccine to protect against Japanese encephalitis received pre-qualification from the World Health Organization (WHO). Story (sub. req.)

> The Scottish Medicines Consortium has approved Lundbeck's Selincro for use by the country's National Health Services as a treatment for alcohol dependence. Article

> In trials, a high dose of Pfizer's ($PFE) tofacitinib proved as effective as Amgen's ($AMGN) Enbrel in treating adults with moderate-to-severe psoriasis. Report

> Amarin's ($AMRN) fish oil pill Vascepa is up for an FDA advisory committee meeting Oct. 16 that will determine whether it becomes the only prescription omega-3 therapy approved for patients with moderately high triglycerides and mixed dyslipidemia. Story

> The FDA is investigating a growing list of reports of non-viral hepatitis in Hawaii that have already led to 11 hospitalizations and one death. Dietary supplement OxyElite Pro appears to be a common link between at least 24 of 29 cases. Report

> Dutch biotech Pharming is placing €12 million ($16.3 million) of new shares to fund the manufacturing of a hereditary angioedema treatment and a clinical trial. Item

Medical Device News

@FierceMedDev: ICYMI: Med tech's hottest takeover targets for the rest of 2013. Special report | Follow @FierceMedDev

> Boston Scientific touts positive data for PAD catheter. More

> Medtronic jumps into hemodialysis business through India partnership. Story

> Medtronic wins FDA panel support to expand pacemaker and defibrillator use. Item

Biotech News

@FierceBiotech: Popular from FierceCRO - Analyst: Bet on another boom for big CROs. Story | Follow @FierceBiotech

@JohnCFierce: ICYMI: 10 top drugs in biopharma's late-stage pipeline. Special report | Follow @JohnCFierce

@DamianFierce: Time to find out whether device firms are allowed at the biotech IPO party: LDR prices a $75M debut. News | Follow @DamianFierce

@EmilyMFierce: Altered antimicrobials could combat drug-resistant bacteria. ICYMI from FierceBiotech Research | Follow @EmilyMFierce

> Ariad hammered on toxicity concerns for leukemia drug Iclusig. News

> Bayer wins key FDA approval for lung disease drug Adempas. More

> Shutdown nixes Merck's FDA panel date, spares other drugs. Story

Drug Delivery News

@MichaelGFierce: Stem cell 'drug factories' target, treat inflammation. More | Follow @MichaelGFierce

> U.S.-based scientists win Nobel Prize for cell transport exploration. Item

> Study: Disc-shaped nanoparticles best at crossing cell membranes. More

> Cook touts positive data for Zilver paclitaxel-eluting stent after April recall. Story

> Alnylam posts positive PhI for RNAi cholesterol drug. Report

Diagnostics News

@MarkHFierce: Sign up for your free, weekly dose of FierceDiagnostics. Sign up here | Follow @MarkHFierce

> Roche looks to the future with two new molecular Dx systems. Article

> Exact Sciences denies talks underway to invest in Israeli cancer Dx startup. Story

> Boreal Genomics pulls in $18M Series C for genomic research and Dx test expansion. Report

> Renishaw Diagnostics seals deal with tech transfer group to develop infectious disease tests. More

And Finally... Three U.S.-based scientists picked up the Nobel Prize in chemistry for developing powerful computer models that researchers can use to explore complex chemical interactions and create new drugs. Story

Suggested Articles

Merck’s Keytruda went up against chemo in a head-to-head colorectal cancer battle—and won.

While the FDA gave an emergency green light to chloroquine's use against coronavirus, European regulators are restricting the drug to clinical trials.

Biocon has finally satisfied the FDA that its insulin production plant in Malaysia is ready for prime time.